bFGF Inhibitors

Basic fibroblast growth factor (bFGF), also known as FGF2, is one of the 22 identified members of the fibroblast growth factor (FGF) family. These proteins play crucial roles in a variety of biological processes, such as angiogenesis, wound healing, embryonic development, and differentiation. The FGF family functions primarily by binding to and activating specific cell surface receptors known as fibroblast growth factor receptors (FGFRs). This binding event leads to receptor dimerization and autophosphorylation, initiating a cascade of downstream signaling events that regulate cell proliferation, differentiation, and migration. The fine-tuned regulation of these signaling pathways is vital for maintaining tissue homeostasis.

bFGF inhibitors are molecules that specifically block or modulate the activity of bFGF. These inhibitors can be of various types, such as small molecules, peptides, antibodies, or aptamers. The mode of action of these inhibitors varies. Some directly bind to bFGF, preventing it from interacting with its receptor. Others might interfere with the receptor's activity, blocking its activation upon bFGF binding. Another set of inhibitors may impede downstream signaling pathways activated by bFGF-FGFR complexes. By disrupting the binding or the resultant signaling cascade, bFGF inhibitors effectively downregulate the biological activities associated with bFGF. The understanding and characterization of these inhibitors are crucial as they provide valuable insights into the molecular mechanisms of bFGF regulation and offer tools for investigating the extensive biological roles of bFGF.